Supply Chain

Specialty pharmaceutical growth poses unique challenges for hospital pharmacies. Effectively managing these high-cost therapies that often have unpredictable volume requires a different inventory management model than traditional pharmaceuticals.

Hospital pharmacies are uniquely positioned to help health systems achieve greater operational efficiency and improve patient care.

FDA Commissioner Scott Gottlieb, MD, unveiled four steps the agency is taking to strengthen its cybersecurity program for medical devices Oct. 1.

In a new environment stacked with seemingly competing goals, hospital leaders are facing more pressure to simultaneously cut costs, expand services and lead new clinical initiatives.

Here are four drugs or medical devices that have been approved by the FDA since Sept. 21:

The FDA is considering imposing financial penalties on researchers who submit false data to the government's clinical trials database, according to a draft guidance posted to the Federal Register Sept. 21.

Hospitals and health systems cannot effectively quantify and control costs without first targeting key expense areas. However, administrators inundated with cost responsibilities regularly overlook major savings opportunities.

Here are four drugs or medical devices that have been approved by the FDA since Sept. 14:

The Food and Drug Administration issued a warning letter to Pharmaceutical Laboratories and Consultants referencing several violations at the Addison, Ill.-based lab, including the presence of a microbrewery in its drug testing area.

Accenture and Merck are building an informatics research platform on Amazon's cloud computing service Amazon Web Services to support data-driven drug development.